http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105943547-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate | 2016-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105943547-B |
| titleOfInvention | The pharmaceutical composition of Anti-HBV activity and its application |
| abstract | The invention provides the pharmaceutical composition comprising 1 (the fluorine β L arabinofuranosidases glycosyl of 2 deoxidation 2) thymidine and its application, for anti-hepatitis B virus. |
| priorityDate | 2016-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.